EUVIMEDEUVIMED entdecken
Crossref

AKR1B10 Serves as a Specific Biomarker for the Identification of Hepatocellular Ballooning Degeneration in MASH Patients

Jin-Zhong Li, Li-Li Zhang, Li-Hong Ye, Wei-Wei Zou, Ya-Juan Qi iD, De-Hua Wang, Ying Cao, Qiang Li, Yi-Fan Han iD, Yun Wang, Er-Hei Dai, Jian-Hua Lu und 8 weitere

Liver International · 2026-07 · 46 (7)

DOI: 10.1111/liv.70712 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, online erschienen am 03.06.2026. Verfasst von Jin-Zhong Li und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Disease, The First Affiliated Hospital of Jinan University, Guangzhou, China. Hauptthemen laut MEDLINE: Hepatocytes, Aldo-Keto Reductase Family 1 member B10, Fatty Liver. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Wang Baoen Liver Fibrosis Research Fund Project, The Young Scientists Fund of the National Natural Science Foundation of China, Medical Science Research Project of Hebei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatocellular ballooning degeneration distinguishes metabolic dysfunction‐associated steatohepatitis (MASH) from metabolic dysfunction‐associated steatotic liver (MASL), yet specific biomarkers are lacking.

Methods

The spatial transcriptomes of liver sections from human MASL and MASH patients and single‐cell data were used to examine hepatocyte ballooning. AKR1B10 and CK8/18 expression in 20 human liver samples were analysed by H&E staining and immunofluorescence. Serum AKR1B10 levels were quantified in 284 patients with various liver aetiologies to assess its differential expression across liver disease types and its diagnostic performance.

Results

Spatial and single‐cell transcriptomic analyses revealed significant AKR1B10 enrichment in the ballooned hepatocytes. The proportions of T cells and fibroblasts were significantly greater in ballooning regions than in steatotic regions. Immunostaining confirmed the localization of AKR1B10 in ballooning regions, along with the cytoplasm and cell membrane. This expression pattern was consistent with areas of cytokeratin CK8/18 loss; moreover, their combined application improved the ballooning diagnostic rate and accuracy. Serum AKR1B10 levels were markedly higher in patients with MASH than in individuals with other liver diseases ( p < 0.01) and correlated with ballooning severity ( R = 0.624). Ordinal logistic regression analysis indicated that the serum AKR1B10 level was strongly positively correlated with liver tissue ballooning severity (OR = 1.541 per unit, p = 0.003). The constructed model demonstrated significant discriminatory ability for identifying MASH patients with ballooning (AUC = 0.863).

Conclusions

AKR1B10 is a potential diagnostic and therapeutic biomarker for hepatocyte ballooning in MASH patients with strong spatial specificity and clinical value for noninvasive diagnosis, disease stratification, and treatment monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatocytesAldo-Keto Reductase Family 1 member B10Fatty LiverHumansBiomarkersMaleFemaleKeratin-18Middle AgedLiverAdultKeratin-8Gene Expression ProfilingAldo-Keto Reductases

Stichwörter der Autor:innen

AKR1B10MASHballooning degenerationspatial transcriptomics

Substanzen

BiomarkersAKR1B10 protein, humanKeratin-18Aldo-Keto Reductase Family 1 member B10Keratin-8KRT18 protein, humanAldo-Keto Reductases

Autor:innen und Institutionen

  • Division of Infectious Disease, The First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Shijiazhuang Second Hospital, Hebei Provincial Key Laboratory of Basic Medicine for Diabetes, Shijiazhuang, China.
  • Division of Pathology, The Fifth Hospital of Shijiazhuang, Hebei Medical University, Shijiazhuang, China.
  • School of Basic Medical Science, North China University of Science and Technology, Tangshan, China.
  • Division of Liver Disease, The Fifth Hospital of Shijiazhuang, Hebei Medical University, Shijiazhuang, China.
  • Center of Liver Diseases Division, Beijing Ditan Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Ya-Juan Qi, Yi-Fan Han, Min-Ran Li

Förderung

  • Wang Baoen Liver Fibrosis Research Fund Project
  • The Young Scientists Fund of the National Natural Science Foundation of China
  • Medical Science Research Project of Hebei Province
  • Beijing Hospitals Authority Youth Program
  • Key project of Traditional Chinese medicine Joint Fund of Hebei Province

Zitieren

APA

Li, J. Z., Zhang, L. L., Ye, L. H., Zou, W. W., Qi, Y. J., Wang, D. H., Cao, Y., Li, Q., Han, Y. F., Wang, Y., Dai, E. H., Lu, J. H., Chen, N., Zhang, H. C., Liu, Z. Q., Yang, L., Pan, Y., Zeng, D. Y., Xiao, M. X., & Li, M. R. (2026). AKR1B10 Serves as a Specific Biomarker for the Identification of Hepatocellular Ballooning Degeneration in MASH Patients. Liver International, 46(7). https://doi.org/10.1111/liv.70712

Vancouver

Li JZ, Zhang LL, Ye LH, Zou WW, Qi YJ, Wang DH, et al. AKR1B10 Serves as a Specific Biomarker for the Identification of Hepatocellular Ballooning Degeneration in MASH Patients. Liver International. 2026;46(7). doi:10.1111/liv.70712

BibTeX
@article{Li2026,
  author = {Li, Jin-Zhong and Zhang, Li-Li and Ye, Li-Hong and Zou, Wei-Wei and Qi, Ya-Juan and Wang, De-Hua and Cao, Ying and Li, Qiang and Han, Yi-Fan and Wang, Yun and Dai, Er-Hei and Lu, Jian-Hua and Chen, Ning and Zhang, Hai-Cong and Liu, Zhi-Quan and Yang, Liu and Pan, Yun and Zeng, Dong-Yu and Xiao, Min-Xi and Li, Min-Ran},
  title = {AKR1B10 Serves as a Specific Biomarker for the Identification of Hepatocellular Ballooning Degeneration in MASH Patients},
  journal = {Liver International},
  year = {2026},
  volume = {46},
  number = {7},
  doi = {10.1111/liv.70712}
}
Kostenlos starten →